Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01986231 · ClinicalTrials.gov registry record · NA
Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver
A NA study, sponsored by Legacy Health System.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01986231 is a NA study that has completed, run by Legacy Health System. The registered enrollment target is 12 participants.
The verdict
NCT01986231, a NA study, has completed, sponsored by Legacy Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if giving multiple doses of a hormone called glucagon can cause a major decrease in liver glycogen (animal starch). Glucagon is currently approved by the Food and Drug Administration to be given as a large dose to treat severe low blood sugar. Our group is studying whether glucagon can be given in repeated small doses to prevent hypoglycemia.
Interventions
- DRUG Glucagon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01986231
The ClinicalTrials.gov registry entry for NCT01986231 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Legacy Health System, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Glucagon is the first listed.
NCT01986231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01986231 about?
NCT01986231 is a clinical study titled "Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver". The purpose of this study is to learn if giving multiple doses of a hormone called glucagon can cause a major decrease in liver glycogen (animal starch). Glucagon is currently approved by the Food and Drug Administration to be given as a large dose to treat severe low blood sugar. Our group is study...
What is the current status of trial NCT01986231?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2011-01. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01986231?
The interventions under investigation include: Glucagon (DRUG).
Who is sponsoring clinical trial NCT01986231?
This trial is sponsored by Legacy Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.